Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Lyons

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Thrombosis and Haemostasis|February 25, 1988
Plasminogen San Antonio: an abnormal plasminogen with a more cathodic migration, decreased activation and associated thrombosisY Liu, R M Lyons, J McDonagh
The Journal of Clinical Investigation|October 1, 1975
Thrombin-induced protein phosphorylation in human plateletsR M Lyons, N Stanford, P W Majerus
Agents and Actions|July 1, 1982
Extra- and intracellular Ca2+ requirements for lysosomal enzyme secretion in human neutrophilsJ O Shaw, I Brodersen, R M Lyons
Biochimica Et Biophysica Acta|June 1, 1990
The cell biology of transforming growth factor betaJ A Barnard, R M Lyons, H L Moses
The Journal of Clinical Investigation|July 1, 1980
Membrane changes associated with platelet activation. Exposure of actin on the platelet surface after thrombin-induced secretionJ N George, R M Lyons, R K Morgan
Molecular Carcinogenesis|January 1, 1990
Isolation and characterization of Kirsten murine sarcoma virus-transformed mouse keratinocytes resistant to transforming growth factor betaN J Sipes, R M Lyons, H L Moses
Cancer Research|December 15, 1987
Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1J Keski-Oja, R M Lyons, H L Moses
American Journal of Hematology|January 1, 1977
Development of chronic myelocytic leukemia during the course of acute lymphocytic leukemia in an adultB L Fisher, R M Lyons, D A Sears
The Journal of Cell Biology|May 1, 1988
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned mediumR M Lyons, J Keski-Oja, H L Moses
Archives of Internal Medicine|November 4, 1998
Comparing different routes and doses of phytonadione for reversing excessive anticoagulationA M Whitling, H I Bussey, R M Lyons
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Thrombosis and Haemostasis|February 25, 1988
Plasminogen San Antonio: an abnormal plasminogen with a more cathodic migration, decreased activation and associated thrombosisY Liu, R M Lyons, J McDonagh
The Journal of Clinical Investigation|October 1, 1975
Thrombin-induced protein phosphorylation in human plateletsR M Lyons, N Stanford, P W Majerus
Agents and Actions|July 1, 1982
Extra- and intracellular Ca2+ requirements for lysosomal enzyme secretion in human neutrophilsJ O Shaw, I Brodersen, R M Lyons
Biochimica Et Biophysica Acta|June 1, 1990
The cell biology of transforming growth factor betaJ A Barnard, R M Lyons, H L Moses
The Journal of Clinical Investigation|July 1, 1980
Membrane changes associated with platelet activation. Exposure of actin on the platelet surface after thrombin-induced secretionJ N George, R M Lyons, R K Morgan
Molecular Carcinogenesis|January 1, 1990
Isolation and characterization of Kirsten murine sarcoma virus-transformed mouse keratinocytes resistant to transforming growth factor betaN J Sipes, R M Lyons, H L Moses
Cancer Research|December 15, 1987
Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1J Keski-Oja, R M Lyons, H L Moses
American Journal of Hematology|January 1, 1977
Development of chronic myelocytic leukemia during the course of acute lymphocytic leukemia in an adultB L Fisher, R M Lyons, D A Sears
The Journal of Cell Biology|May 1, 1988
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned mediumR M Lyons, J Keski-Oja, H L Moses
Archives of Internal Medicine|November 4, 1998
Comparing different routes and doses of phytonadione for reversing excessive anticoagulationA M Whitling, H I Bussey, R M Lyons
Pageof 5